BAXTER INTL  DL 1 logo

BAXTER INTL DL 1 (BTL)

Market Closed
8 Jan, 20:00
XHAN XHAN
28. 51
+0.21
+0.76%
- Market Cap
84.13 P/E Ratio
0.68% Div Yield
0 Volume
2.59 Eps
28.3
Previous Close
Day Range
28.41 28.51
Year Range
27.64 40.26
Earnings results expected in 22 days

Summary

BTL closed Wednesday higher at €28.51, an increase of 0.76% from Tuesday's close, completing a monthly increase of 2.11% or €0.59. Over the past 12 months, BTL stock gained 2.11%.
BTL pays dividends to its shareholders, with the most recent payment made on Jan 02, 2025.
The last earnings report, released on Nov 08, 2024, exceeded the consensus estimates by 0.02%. On average, the company has surpassed earnings expectations by 0.01%, based on the last three reports. The next scheduled earnings report is due on Feb 06, 2025.
The stock of the company had never split.
The company's stock is traded on 10 different exchanges and in various currencies, with the primary listing on XHAN (EUR).
Want to track BTL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

BTL Chart

FAQ

What Is the BAXTER INTL DL 1(BTL) Stock Price Today?

The BTL stock price today is €28.51.

What Stock Exchange Does BAXTER INTL DL 1 Trade On?

BAXTER INTL DL 1 is listed and trades on the NYSE.

What Is the Stock Symbol for BAXTER INTL DL 1?

The stock symbol for BAXTER INTL DL 1 is "BTL".

Does BAXTER INTL DL 1 Pay Dividends? What's The Current Dividend Yield?

BTL is not paying dividends to its shareholders.

What Is the BAXTER INTL DL 1 Market Cap?

As of today, BAXTER INTL DL 1 does not have a market cap available.

What is BAXTER INTL DL 1 Earnings Per Share?

The BAXTER INTL DL 1 EPS is 0.

What Is the Next BAXTER INTL DL 1 Earnings Date?

BAXTER INTL DL 1 will release its next earnings report on Feb 06, 2025.

Did BAXTER INTL DL 1 had any splits?

No, BAXTER INTL DL 1 has never had a stock split.

BAXTER INTL DL 1 Profile

Medical Instruments & Supplies Industry
Healthcare Sector
Mr. Jose E. Almeida CEO
XHAN Exchange
US0718131099 ISIN
US Country
60,000 Employees
2 Jan 2025 Last Dividend
1 Jul 2015 Last Split
27 Oct 1981 IPO Date

Overview

Baxter International Inc. is a global healthcare company with a history dating back to 1931. With its headquarters in Deerfield, Illinois, Baxter specializes in the development and distribution of a wide range of healthcare products aimed at enhancing the health and well-being of people around the world. The company's operations are segmented into four key areas: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. These segments allow Baxter to serve a diverse range of healthcare needs, from critical care to chronic disease management. Baxter's commitment to innovation and quality is evident in its extensive product portfolio and its global presence, selling products in approximately 100 countries through a combination of direct sales force and distributors, including drug wholesalers and specialty pharmacy providers. The company's collaborative efforts, such as agreements with Celerity Pharmaceutical, LLC, and Miromatrix Medical Inc., underscore its dedication to advancing healthcare solutions.

Products and Services

  • Sterile Intravenous (IV) Solutions

    These are critical for patient hydration, medication delivery, and various forms of therapy in clinical settings.

  • Infusion Systems and Devices

    Baxter offers advanced infusion systems and devices that facilitate the safe and precise delivery of IV medications and therapies.

  • Parenteral Nutrition Therapies

    Designed for patients who cannot eat or absorb nutrients through their digestive system, these therapies provide vital nutrition intravenously.

  • Generic Injectable Pharmaceuticals

    The company supplies a range of generic injectables, including essential drugs for acute care settings.

  • Surgical Hemostat and Sealant Products

    These products are utilized to control bleeding and promote healing in surgical procedures.

  • Advanced Surgical Equipment

    Baxter provides state-of-the-art surgical equipment, including surgical video technologies and precision positioning devices, to enhance surgical efficiency and outcomes.

  • Smart Bed Systems

    These systems are designed to improve patient comfort and monitoring capabilities in healthcare settings.

  • Patient Monitoring and Diagnostic Technologies

    Baxter offers technologies for continuous monitoring and diagnosis of patients, aiding in timely and accurate healthcare delivery.

  • Respiratory Health Devices

    Devices designed to assist with breathing disorders and respiratory health management.

  • Dialysis Therapies and Services

    Providing a comprehensive suite of dialysis therapies and services, including peritoneal dialysis (PD) and hemodialysis (HD), Baxter supports patients with chronic kidney failure.

  • Adhesion Prevention Products

    These products are designed to prevent post-surgical adhesions, enhancing patient recovery and comfort.

  • Drug Compounding

    Baxter offers specialized compounding services, allowing for customized medication formulations to meet unique patient needs.

  • Inhaled Anesthesia

    Offering a range of inhaled anesthesia products, Baxter supports anesthesiologists in providing safe and effective sedation for surgical procedures.

Contact Information

Address: One Baxter Parkway, Deerfield, IL, United States, 60015
Phone: 224 948 2000